<DOC>
	<DOCNO>NCT00302484</DOCNO>
	<brief_summary>Patients terminal chronic liver disease disorder bone metabolism result high risk fall ill osteoporosis . Although liver transplantation restore liver function , immunosuppressive therapy ( especially corticosteroid ) transplantation increase risk osteoporosis bone fragility . Zoledronate , bisphosphonate , slow destruction bone . The purpose study determine whether bisphosphonates effective prevention osteoporosis follow immunosuppressive therapy liver transplantation .</brief_summary>
	<brief_title>Use Bisphosphonates Treatment Osteopathy After Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>primary liver transplantation retransplantation within two week write informed consent Age â‰¥ 18 year chronic kidney disease : Creatinine Clearance &lt; 35 ml/min Serum Creatinine &gt; 2,5 mg/dl know hypersensitivity Zoledronate , recipients drug bone specific medication ( Bisphosphonate , Fluoride , Calcitonin ) within last three month liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>